Sofinnova Investments’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-253,262	Closed	-$13.6M	–	73
2024 Q4	$13.6M	Buy	253,262 +88,492	+54%	+$4.74M	0.99%	27
2024 Q3	$7.49M	Buy	+164,770	New	+$7.49M	0.59%	34